🇺🇸 FDA

Company profile · Sponsor

Fudan

Fudan University

C6D6342 · NMPA pharma CN
Pipeline
4
Drugs
0
Patents
0

Quick answer

Fudan (C6D6342) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 4 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker C6D6342
Exchange NMPA
Company type pharma
Headquarters CN

Pipeline (4)

Search pipeline →

  1. tissue-of-origin (ORIGIN-PanCA○R) profiling

    Fudan

    Cancer of Unknown Primary Site

    phase 3 gene therapy completed

    1 trial

  2. EOF5

    Fudan

    Gastric Cancer

    phase 2 small molecule completed

    1 trial

  3. IGEV

    Fudan

    Hodgkin Lymphoma

    phase 2 small molecule active

    1 trial

  4. anlotinib

    Fudan

    Extensive-stage Small Cell Lung Cancer

    phase 2 small molecule active

    1 trial

Frequently asked questions

What is Fudan?

Fudan (C6D6342) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 4 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Fudan sponsor?

We track 4 ClinicalTrials.gov-linked programs for Fudan, including tissue-of-origin (ORIGIN-PanCA○R) profiling and 3 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Fudan company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.